3A3232).
Introduction
A number of recent studies have indicated that locally produced estrogen regulates follicular and luteal development and steroidogenesis in the ovary (1-3). To obtain a better understanding of estrogen metabolism, it is very important to examine the enzyme P450 aromatase (P45Oarom). which catalyzes the conversion of androgen to estrogen. In human ovary, several immunohistochemical studies on P45Oarom have been reported (4-9). However, extensive analyses of P450arom catalytic activity in normal cycling human ovary have not been performed except for a report by Sano et al. (lo) , and chronological changes in the P450arom enzymatic activity throughout the menstrual cycle remain unclear.
P45Oarom activity is regulated by the number of P450arom moll Correspondence to: Hironobu Sasano, MD, Dept. of Pathology, Tohoku U. School of Medicine, 2-1, Seiryo-machi, Aoba-ku. Sendai 980, Japan. ular phase, P450arom was observed in the granulosa cells of one selected antral follicle per case during the mid-to late proliferative period, and its immunointensity per granulosa cell in the follicle was not significantly different between mid-and late proliferative periods, although serum estradiol level was markedly elevated in the late ptoliferative period. In the luteal phase, both P450arom immunointensity per luteinized granulosa cell in a corpus luteum and serum estradiol level reached a peak in the mid-secretory period. These findings indicate that different factors may influence ovarian P45Oarom activity during the follicular and luteal phases, i.e., an increased number of granulosa cells in the selected follicle during the follicular phase but changes in P450arom activity per luteinized granulosa cell in the corpus luteum during the luteal phase. (1 tListochem cytochem 1994) KEY WORDS: Aromatase; Image processing; Immunohistochemistry; Human ovary; Menstrual cycle. ecules rather than by changes in the catalytic ability of each molecule (11) (12) (13) . Inkster et al. (14) examined P450arom expression in the human placenta immunohistochemically and biochemically, and proposed that P450arom activity might be evaluated by quantitation of P4SOarom immunointensity (14) . However, it is well recognized that quantitation of immunoreactivity is difficult, and new techniques to quantify with reasonable accuracy the amount of immunoreactivity in tissue sections would be very helpful.
Computerized image analysis, including the CAS 200 computed image analysis system employed in this study, has improved remarkably over the past few years. An accurate determination of the amount of immunointensity on different slides is still difficult, but objective evaluation of different slides has improved by employing these instruments. Therefore, in this study, as an initial step for determining the amount of P450arom activity in human ovary, we investigated the optimal conditions for tissue fixation and the optimal immunohistochemical procedures for measuring P450arom immunointensity on tissue sections using the CAS 200 computed image analysis system and three human placental specimens. We then studied the correlation between P450arom immunointensity per cell and its catalytic activity per lo6 cells as determined by the tritiated water method, using five estrogen-producing human cancer cell lines. Based on the results of these experiments, we applied this technique to examine P45Oarom activity in 31 normal cycling human ovaries and to analyze changes in P450arom activity throughout the menstrual cycle.
Materials and Methods

Materials
Placentas. Three full-term normal human placentas were obtained during normal deliveries at Tohoku University Hospital, Sendai, Japan. All tissues were trimmed into 2 x 1 x 0.5 cm pieces and immediately fixed in one of the following fixatives: (a) 4% paraformaldehyde (PFA) pH 7.4; (b) regular 10% formalin bufkr; (c) neutral 10% formalin buffer. pH 7.4; (d) Zamboni's buffer; (e) paraformaldehyde-lysine-periodate buffer (PLP); and (f) 100% ethanol. The tissue was fixed for 12 hr at 4'C in these fixatives. In 4% PFA fixation, a portion of each tissue was removed from the fixative after 0 (immediately), 3, 6, 12, 18, 24, 48, 72, and 168 hr ( = 7 days) at 4'C. All specimens were subsequently embedded in regular paraffin.
Cell Lines. Five human carcinoma cell lines used in this study included four endometrial adenocarcinoma cell lines [HHUA (15), Ishikawa (16), HEC-59 (17), and OMC-2 (l8)l and one breast carcinoma cell line ]. All cell lines were maintained as monolayer cultures in Eagle's minimal essential medium (EMEM) supplemented with 10% fetal bovine serum (FBS). They were cultured at 37°C in a humidified atmosphere containing 5% c O~/ 9 5~h air.
Ovaries. Ovarian tissue was obtained from 31 women with normal menstrual cycles (26 to 45 years old). In all patients, a unilateral oopohrectomy was performed with a hysterectomy for squamous cell carcinoma of the uterine cervix, to exclude possible metastasis, at Tohoku University Hospital and other affiliated Hospitals in Sendai, Japan. Histopathological examination in these specimens did not reveal any significant morphological abnormalities. The ovaries were immediately fixed in 4% PFA for 12 hr at 4'C and were subsequently embedded in regular paraffin. Each specimen was classified into one of the following seven phases of the menstrual cycle by endometrium dating and clinical menstrual history. The follicular phase was divided into the early (>7 days before ovulation; n = 3), mid-(4-7 days before ovulation; n = 6), and late (within 3 days before ovulation and inclusion of the ovulatory day; n = 6) proliferative periods. The luteal phase was divided into the early (within 3 days after ovulation; n = 2), mid-(4-6 days after ovulation; n = 4). and late (7-10 days after ovulation; n = 5 ) secretory periods, and the premenstrual (11 days or more after ovulation; n = 5 ) period. Serum estradiol level was also examined using a coated tube radioimmunoassay (RIA) kit (Diagnostic Products; Los Angeles, CA) in all cases.
P450arom Assay by the Zitiated Water Method
Monolayer cultured cells of all cell lines were incubated during their logarithmic growth phase in 75 cm2 culture flasks (Costar; New York, NY).
In the logarithmic growth phase. the medium was changed with phenol red-free EMEM supplemented with 10% dextran-coated, charcoal-filtered FBS at 24 hr before the measurement of P45Oarom activity. To initiate the assay, [lb3H]-androstendione (61.05 x lo6 dpm/nM) (New England Nuclear; Boston, MA) was added to the culture medium to yield a concentration of 100 nM. After 24 hr, 2 ml of culture medium (from a total of 5 ml) was removed and mixed with 1 ml of 20% trichloroacetic acid ('EA) and 1 ml of 5 % charcoal suspension. The mixture was vortexed several times over a 30-min period, centrifuged for 30 min at 3000 rpm, and the supernatant removed and filtered. Aliquots were then measured using a liquid scintillation counter (Beckman 6000IC; Fullerton, CA). The cells remaining on the culture flasks after the removal of the supernatant were trypsinized with 0.25% trypsin-Hanks balanced salt solution to obtain single cell suspensions. Trypsinization was terminated by adding fresh medium. The cell suspension was pipetted and the cells were counted with a hemocytometer. All P45Oarom enzymatic activity was evaluated with lo6 cells.
Culture Cell Preparations for Immunohistochemistry
In all cultured cell lines examined, in the logarithmic growth phase the medium was exchanged with phenol red-free EMEM supplemented with 10% dextran-coated, charcoal-filtered FBS for 24 hr. Testosterone was subsequently added to the culture medium to yield a final concentration of 100 nM. After 24 hr, the monolayer-cultured cells were detached from the bottom of the 75 cm2 culture flasks with 2-mm diameter glass beads (Falcon; Becton Dickinson, Lincoln Park, NJ). Some fragments of the cell layers floating in the medium were centrifuged at 1000 rpm. The supernatant was discarded and the cell pellets were re-suspended in Cytoblock reagent (Cytoblock Kit; Shandon, Pittsburgh, PA). The cell suspension was transferred into Cytoblock cassettes (Cytoblock Kit; Shandon) and the Cytoblock cassettes were centrifuged at 1500 rpm for 15 min, using a Cytospin. The Cytoblock containing the cells was fixed with 4% PFA for 30 min and then embedded with regular paraffin.
Antibody to P450arom
A rabbit IgG fraction of the antiserum against the purified P450arom was kindly donated by Dr. N. Harada (Fujita-Gakuen Health University, Toyoake, Japan) and was prepared as previously described (20) . Cytochrome P450 was purified and the antibody against this aromatase inhibited over 80% of aromatization in vitro (20) . A single band was obtained from placental microsomes or homogenates via Western blotting with this antibody (20) .
Immunohistochemical Procedures
All specimens were sectioned into 3 -~m slices and placed on regular clean glass slides (Matsunami; Tokyo, Japan). Immunohistochemistry was performed as follows. The deparaffinized sections were placed in 100% methanol with 0.3% H202 for 25 min to block endogenous peroxidase activity and were then treated with 1% normal goat serum for 50 min at room temperature (RT). The primary antibody (1:700 dilution) was incubated with the sections for 18 hr at 4°C. After washing in 0.01 M PBS, the sections were incubated with biotinylated anti-rabbit Ig for 40 min at RT and then with peroxidase-conjugated streptavidin (Nichirei; Tokyo, Japan) for 25 min at RT. The antigen-antibody complexes were subsequently visualized by immersion in 3,Y-diaminobenzidine (DAB) solution (0.001 M DAB, 0.05 M Tris-HC1 buffer, pH 7.6, 0.01 M sodium azide, and 0.006% H202) for 3 min. Sections were counterstained with ethyl green (Cell Analysis Systems; Elmhurst, IL) for 10 min at RT, dehydrated in 1-butanol, cleared in xylene, and mounted. Deviations from this basic protocol are specified in the Results section.
For negative controls, the primary antibody was omitted and pre-immune rabbit serum was used instead of the primary antibody. In addition, the primary antibody pre-absorbed with an excess of purified human placental P45Oarom was used. As previously described (20) , the specific prepara-SUZUKI, SASANO, SASAKI, FUKAYA, NAGURA 1000-
tion used in the present study showed approximately 90% purity on SDS-PAGE electrophoresis.
Quantitation of P450arom Immunoreactivity
The CAS 200 computed image analysis system (Cell Analysis Systems) was used for the quantitation of P450arom immunostaining and has been described in detail previously (21) . Briefly, it is a microscope-based, two-color system (500 nm and 620 nm) that uses two solid-state image-sensing channels. The analog video signals of the images are digitized and stored at 256 x 256 pixels. For quantitation of P45Oarom immunoreactivity, we used a newly developed imaging program of "object with dual threshold two wavelengths." The total optical density (OD) of P45Oarom visualized by DAB in the cytoplasm was calculated only from the 500-nm channel, and the number of nuclei stained by ethyl green was calculated only from the 620-nm sensor. For each specimen, six P45Oarom-positive high-power fields [two-dimensional area of the field is 134 pm x 76 pm = 10.2 (W9 m2)] were selected at random, the O D~M and the number of nuclei were measured, and the mean OD of P450arom per cell was subsequently calculated. The high-power field included some areas which were not used for the data collection, and these areas were excluded from the measurement. Statistical analyses were performed using the Welch t-test, andp<0.05 was considered statistically significant. In the human ovary, statistical analysis of the early secretory period was excluded because of the small sample size (n = 2).
Results
No specific immunoreactivity was observed when the primary antibody was omitted, when pre-immune rabbit serum was used instead of the primary antibody, or when the primary antibody was pre-absorbed with an excess of purified P450arom, as previously reported (6, 22) . Immunointensity in negative control sections or P45Oarom-negative fields was evaluated as zero (ODkell) by the CAS 200 computed image analysis system.
Eflects of Tissue Processing and Immunostaining on P4SOarom Immunoreactivity
To evaluate the influence of various fixatives on P450arom immunoreactivity, we performed comparative immunostaining using three human placental specimens that were fixed with six different fixatives as described in Materials and Methods, as a preliminary study. In all placental specimens, regardless of type of fixation, P450arom was observed in the cytoplasm of syncytiotrophoblasts of the chorionic villi. These fmdings were in agreement with previous studies (6, 12, 14) . The results of P450arom immunointensity per syncytiotrophoblast in the various fiiatives (mean i SD ODkell) are summarized in Figure 1 . As shown in Figure 1 , the highest intensity was obtained after fixation with 4% PFA (725.9 k 94.1).
We then investigated the influence of the duration of fixation in 4% PFA. We used three placental specimens fixed with 4% PFA for nine different lengths of time. As shown in Figure 2 We also examined the effect of the duration of DAB reaction, which can be also critical in the quantitation of immunoreactivity. We used three placental specimens fixed with 4% PFA for 12 hr at 4°C. The slides were removed from the DAB solution after 0 (immediately), 1, 2, 3.4, 5, 6, or 7 min. These results are shown in Figure 3 . P45Oarom immunointensity increased up to 2 min (2 min, 671.0 k 63.6). Between 2 and 5 min, the immunoreactivity reached a plateau (5 min, 809.9 i 83.3). After 5 min the intensity increased again, as DAB staining time increased (7 min, 1527.2 i 390.8). Because nonspecific DAB depositions increased significantly after 5 min, we concluded that an incubation period of 2-5 min was the optimal DAB staining time for evaluating the immunoreactivity of P4 >Oarom in tissue sections. 
Correlation Between P4SOarom Catalytic Activity and Its Immunointensity
We examined the correlation between P450arom catalytic activity per IO6 cells, measured by the tritiated water method, and its immunointensity per cell by the CAS 200 image analysis system, using five estrogen-producing cell lines in the logarithmic growth phase and those which were fixed with 4% PFA and embedded in paraffin. These results are shown in Figures 4A, 4B, Figure 5 , a statistically significant correlation (Y = 0.959) was observed between these two variables. The optimal fixative time for cultured cells was determined by a preliminary study (data not shown).
In our preliminary studies, the mean ratio of P45Oarom immunointensity in the confluent condition to that in the logarithmic growth phase in these cell lines was 1.104 * 0.292 (mean f SD). Therefore, influence of cell culture conditions on P450arom enzymatic activity was not significant.
Quantitation of P4S Oarom Immunoreactivity in Human Ovary
To examine chronological changes in P4SOarom activity in human ovary throughout the menstrual cycle, we performed immunohistochemistry for P450arom in 31 ovaries and quantified its immunointensity per cell. To quantify P45Oarom immunointensity as precisely as possible, we used ovarian tissues that were fixed under optimal conditions (4% PFA for 12 hr at 4°C) and performed immunohistochemistry as carefully as possible under the basic pro-tocol described in the Materials and Methods, which is the optimal procedure.
As described in our previous study of immunolocalization of P450arom and other steroidogenic enzymes in normal cycling human ovary (9), P450arom immunoreactivity was observed only in one selected antral follicle or corpus luteum per case from the midproliferative period of the follicular phase to the premenstrual period of the luteal phase. During the mid-to late proliferative periods of the follicular phase, P45Oarom was observed in the granulosa cells of a selected antral follicle, and all the granulosa cells expressed P450arom homogeneously ( Figure 6A ). In the luteal phase, the luteinized granulosa cells of a corpus luteum were positive for P45Oarom ( Figures 6B and 6C ). In the premenstrual period, P450arom expression in the corpus luteum was extremely weak (Figure 6C) . Several non-selected antral follicles or degenerating corpora lutea, which had passed the premenstrual period, were observed in all periods of the menstrual cycle, but they were negative for P450arom.
P450arom immunointensity per (luteinized) granulosa cell in a selected follicle or corpus luteum and plasma concentration of estradiol in each menstrual cycle are shown in Figures 7A and 7B . In the selected follicle, no apparent statistical differences were observed between the mid-and late proliferative periods (297.3 * 133.4 and 335.2 * 101.2, respectively), although serum estradiol level was greatly elevated in the late proliferative period [between the mid-(44.9 * 19.7) and late (125.3 * 45.3) proliferative periods; p<O.Ol]. A selected follicle was not observed in the ovary in the early proliferative period, as described above. In the corpus luteum, maximal P450arom immunointensity was observed in the midsecretory period (1692.2 * 200.7), then gradually decreased (between the mid-secretory and premenstrual periods (611.0 * 195.6; p<O.OOl), and this change was consistent with that of the serum estradiol level during the luteal phase.
P450arom immunointensity of non-selected antral follicles or degenerating corpora lutea was measured as zero by the CAS 200 image analysis system. P450arom kmunointensity was significantly different between these non-selected antral follicles and selected antral follicles in the mid-and late proliferative periods (p<O.Ol, respectively), and between degenerating corpora lutea and corpora lutea in the luteal phase (p<O.OOl vs mid-secretory period;p<o.Ol vs late and premenstrual periods).
A high-power field examined by the CAS 200 image analysis system included some areas that we did not use for the data collection, i.e., theca interna layers and follicular antrum in a selected antral follicle ( Figure 6A ), and stromal cells in a corpus luteum ( Figures 6B and 6C) . These areas were excluded from the measurement. In our present study, the mean number of (luteinized) granulosa cells in the mean two-dimensional area of these cells in a high-power field [10.2 (10-9 mZ)] was 38.6 f 11.5 (cells) in 4.6 f 1.6 (I--9 m2) in the follicular phase, and 8.6 * 3.7 (cells) in 8.6 * 1.0 10-9 mZ) in the luteal phase.
Discussion
Biochemical P450arom activity has been demonstrated in various human tissues (10, 12, (23) (24) (25) . However, in normal cycling human ovary, biochemical P450arom activity has been reported only by linearly as pregnancy progressed. However, the biochemical P450arom activity was comparable to the P45Oarom concentration during pregnancy. These results suggest that P45Oarom activity is largely regulated by the number ofP450arom molecules rather than by alterations in the catalytic ability of each molecule (12) . Inkster et al. (14) examined P450arom expression in human placenta immunohistochemically and biochemically, and proposed that the quantitation of P450arom immunoreactivity might be an important new technique to evaluate P450arom activity (14) . The results of our present study demonstrated a strong correlation between P450arom catalytic activity per lo6 culture cells and its immunointensity per cell, if examinations were performed under the proper conditions. Therefore, it is possible to deduce P450arom activity per cell in native environments from P450arom immunointensity in tissue sections, as proposed by Inkster et al. (14) . This technique could be a useful tool for qualitative evaluation of P45Oarom enzymatic activity in various histological specimens. Moreover, Doody et al. (11) examined the mRNA levels of P450 cholesterol side-chain cleavage ( P~~~S C C ) , @-hydroxysteroid dehydrogenase (3PHSD), P450 17a-hydroxylase (P450c17), and P450arom in human ovary by Northem analysis, and reported that the expression of the mRNAs of steroidogenic enzymes in human ovary was generally consistent with previous reports on the corresponding enzyme activity, and suggested that the latter was a consequence of the former. Therefore, it is likely that not only P450arom but also P45Oscc, @HSD, and P450c17 immunoreactivities may reflect their respective enzymatic activities in human ovary.
However, the accurate determination of immunointensity, especially among different tissue sections, is quite difficult. Our present results also revealed that immunoreactivity was greatly influenced by a number offactors, including type offiiuve employed, duration of fixation, and immunohistochemical procedures. In addition, it is difficult to obtain objective values of immunointensity without the use of computerized image analysis. Moreover, it is difficult to biochemically analyze the significance of immunoreactivity. Therefore, to perform a reasonably accurate quantitation of immunoreactivity on tissue sections, it is essential to determine the optimal conditions for immunostaining.
In menstruating women, it is generally accepted that plasma estradiol level increases to its maximal concentration immediately before ovulation and falls sharply thereafter, and it is elevated again as a second peak in the mid-secretory period (26,27). Doody et al. (11) demonstrated that serum estradiol level throughout the human ovarian cycle might be largely determined by the amount of P45Oarom mRNA expression. Lephart et al. (13) reported that P450arom mRNA level was correlated with this enzyme activity and the serum estradiol level in rat ovary. These findings suggest that periodic changes in serum estradiol level throughout the human menstrual cycle are predominantly determined by P45Oarom enzymatic activity in the ovary. During the mid-to late proliferative periods of the follicular phase, P450arom was observed in the granulosa cells of one selected antral follicle per case. The serum estradiol level increased markedly in the late proliferative period (between the mid-and late proliferative periods; p<o.ol), but P450arom immunointensity per granulosa cell in the selected follicle was statistically comparable between the mid-and late proliferative periods. Therefore, an increase in serum estradiol concentration in the late proliferative period may be due to an increase in the number of granulosa cells in the selected antral follicle corresponding to follicular development, and not necessarily due to an increase in P45Oarom activity per granulosa cell in the follicle.
During the luteal phase, both P450arom immunointensity per luteinized granulosa cell in a corpus luteum and serum estradiol level peaked in the mid-secretory period and then gradually decreased. In the premenstrual period, P450arom expression was extremely weak in luteinized granulosa cells. These data suggest that changes in serum estradiol concentration during the luteal phase reflect changes in the P45Oarom activity per luteinized granulosa cell throughout the process of luteal development and regression, rather than a change in the number of luteal cells.
Results of various recent studies have demonstrated that luteal development and regression are regulated by various factors, including luteinizing hormone (LH) ( 2 8 ,~) and progesterone (30). These studies suggest that P45Oarom activity in the luteal phase may be regulated by these factors, which are different from those during the follicular phase. In addition, San0 et al. (10) and Doody et al. (11) postulated that estrogen biosynthesis in the luteal phase is regulated predominantly by the supply of the substrates for aromatization rather than by ovarian P45Oarom activity. Therefore, on the basis of the results of our study and the previous studies described above, ovarian P45Oarom activity and estrogen biosynthesis during the luteal phase may be regulated by mechanisms that are different from those during the follicular phase.
P450arom expression in a selected antral follicle appears to be stronger than that in a corpus luteum (Figures 6A-6C ). This can be explained by the fact that a granulosa cell in a selected follicle is much smaller than a luteinized granulosa cell in a corpus luteum. In our present study, a luteinized granulosa cell in a corpus luteum contains much larger amounts of P450arom (two to six times) than a granulosa cell in a selected follicle. However, the mean twodimensional area per luteinized granulosa cell was approximately eight times larger than that per granulosa cell in a selected follicle.
In conclusion, we demonstrated that P450arom immunointensity per cell correlated well with the P45Oarom enzymatic activity. We applied this technique to the investigation of changes in P45Oarom activity in human ovary throughout the menstrual cycle. In the follicular phase, ovarian P45Oarom activity was mainly influenced by the number of granulosa cells in one selected follicle. In the luteal phase, however, changes in P450arom activity per luteinized granulosa cell in a corpus luteum largely reflected ovarian P450arom activity. Therefore, ovarian P45Oarom activity ana estrogen biosynthesis during the luteal phase may be regulated by factors that differ from those during the follicular phase. Since this quantitative technique of P450arom immunoreactivity on tissue sections is relatively easy and straightforward, it can be applied to interpretation of P450arom activity in various organs.
